Neural Stem Cells Exposed to BrdU Lose Their Global DNA Methylation and Undergo Astrocytic Differentiation

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2012 Mar 2

PMID 22379135

Citations 14

Authors

Leonid Schneider

Fabrizio dAdda di Fagagna

Affiliations

Soon will be listed here.

Abstract

Bromodeoxyuridine (5-bromo-2'-deoxyuridine, BrdU) is a halogenated nucleotide of low toxicity commonly used to monitor DNA replication. It is considered a valuable tool for in vitro and in vivo studies, including the detection of the small population of neural stem cells (NSC) in the mammalian brain. Here, we show that NSC grown in self-renewing conditions in vitro, when exposed to BrdU, lose the expression of stem cell markers like Nestin, Sox2 and Pax6 and undergo glial differentiation, strongly up-regulating the astrocytic marker GFAP. The onset of GFAP expression in BrdU exposed NSC was paralleled by a reduced expression of key DNA methyltransferases (DNMT) and a rapid loss of global DNA CpG methylation, as we determined by our specially developed analytic assay. Remarkably, a known DNA demethylating compound, 5-aza-2'-deoxycytidine (Decitabine), had similar effect on demethylation and differentiation of NSC. Since our key findings apply also to NSC derived from murine forebrain, our observations strongly suggest more caution in BrdU uses in stem cells research. We also propose that BrdU and its related substances may also open new opportunities for differentiation therapy in oncology.

Citing Articles

5-Bromo-2'-deoxyuridine labeling: historical perspectives, factors influencing the detection, toxicity, and its implications in the neurogenesis.

Marti-Clua J Neural Regen Res. 2023; 19(2):302-308.

PMID: 37488882 PMC: 10503596. DOI: 10.4103/1673-5374.379038.

Methods for Inferring Cell Cycle Parameters Using Thymidine Analogues.

Marti-Clua J Biology (Basel). 2023; 12(6).

PMID: 37372169 PMC: 10295744. DOI: 10.3390/biology12060885.

Unexpected BrdU inhibition on astrocyte-to-neuron conversion.

Wang T, Liao J, Wang X, Wang Q, Wan K, Yang Y Neural Regen Res. 2021; 17(7):1526-1534.

PMID: 34916438 PMC: 8771121. DOI: 10.4103/1673-5374.325747.

A simple flow cytometry-based assay to study global methylation levels in onion, a non-model species.

Somasundaram S, Satheesh V, Singh M, Anandhan S Physiol Mol Biol Plants. 2021; 27(8):1859-1865.

PMID: 34539120 PMC: 8405793. DOI: 10.1007/s12298-021-01047-6.

Incorporation of 5-Bromo-2'-deoxyuridine into DNA and Proliferative Behavior of Cerebellar Neuroblasts: All That Glitters Is Not Gold.

Marti-Clua J Cells. 2021; 10(6).

PMID: 34200598 PMC: 8229392. DOI: 10.3390/cells10061453.

References

Levkoff L, Marshall 2nd G, Ross H, Caldeira M, Reynolds B, Cakiroglu M . Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo. Neoplasia. 2008; 10(8):804-16. PMC: 2504767. DOI: 10.1593/neo.08382. View

Hatada I, Morita S, Kimura M, Horii T, Yamashita R, Nakai K . Genome-wide demethylation during neural differentiation of P19 embryonal carcinoma cells. J Hum Genet. 2008; 53(2):185-191. DOI: 10.1007/s10038-007-0228-0. View

Minagawa S, Nakabayashi K, Fujii M, Scherer S, Ayusawa D . Early BrdU-responsive genes constitute a novel class of senescence-associated genes in human cells. Exp Cell Res. 2005; 304(2):552-8. DOI: 10.1016/j.yexcr.2004.10.036. View

Glaser T, Pollard S, Smith A, Brustle O . Tripotential differentiation of adherently expandable neural stem (NS) cells. PLoS One. 2007; 2(3):e298. PMC: 1808430. DOI: 10.1371/journal.pone.0000298. View

Schneider L, Fumagalli M, dAdda di Fagagna F . Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency. Cell Death Differ. 2011; 19(4):582-91. PMC: 3307974. DOI: 10.1038/cdd.2011.129. View

Ross H, Rahman M, Levkoff L, Millette S, Martin-Carreras T, Dunbar E . Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells. J Neurooncol. 2011; 105(3):485-98. PMC: 3202677. DOI: 10.1007/s11060-011-0621-6. View

Altman J, Das G . Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 1965; 124(3):319-35. DOI: 10.1002/cne.901240303. View

Spiliotopoulos D, Goffredo D, Conti L, Di Febo F, Biella G, Toselli M . An optimized experimental strategy for efficient conversion of embryonic stem (ES)-derived mouse neural stem (NS) cells into a nearly homogeneous mature neuronal population. Neurobiol Dis. 2009; 34(2):320-31. DOI: 10.1016/j.nbd.2009.02.007. View

Sen G, Reuter J, Webster D, Zhu L, Khavari P . DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature. 2010; 463(7280):563-7. PMC: 3050546. DOI: 10.1038/nature08683. View

10.

KAUFMAN E . The role of deoxyribonucleotide metabolism in 5-bromo-2'-deoxyuridine mutagenesis in mammalian cells. Mutat Res. 1988; 200(1-2):149-55. DOI: 10.1016/0027-5107(88)90077-2. View

11.

Palii S, Van Emburgh B, Sankpal U, Brown K, Robertson K . DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol. 2007; 28(2):752-71. PMC: 2223421. DOI: 10.1128/MCB.01799-07. View

12.

Singer J, STELLWAGEN R, Riggs A . 5-Methylcytosine content of rat hepatoma DNA substituted with bromodeoxyuridine. J Biol Chem. 1977; 252(15):5509-13. View

13.

Hoshino T, Nagashima T, Cho K, Davis R, Donegan J, Slusarz M . Variability in the proliferative potential of human gliomas. J Neurooncol. 1989; 7(2):137-43. DOI: 10.1007/BF00165098. View

14.

dAdda di Fagagna F . Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008; 8(7):512-22. DOI: 10.1038/nrc2440. View

15.

Gratzner H . Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science. 1982; 218(4571):474-5. DOI: 10.1126/science.7123245. View

16.

Takagaki K, Katsuma S, Kaminishi Y, Horio T, Tanaka T, Ohgi T . Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells. Genes Cells. 2005; 10(2):97-106. DOI: 10.1111/j.1365-2443.2005.00821.x. View

17.

Meissner A, Mikkelsen T, Gu H, Wernig M, Hanna J, Sivachenko A . Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008; 454(7205):766-70. PMC: 2896277. DOI: 10.1038/nature07107. View

18.

Banerjee S, Bacanamwo M . DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. Exp Cell Res. 2009; 316(2):172-80. PMC: 2788076. DOI: 10.1016/j.yexcr.2009.08.011. View

19.

So A, Jung J, Lee S, Kim H, Kang K . DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. PLoS One. 2011; 6(5):e19503. PMC: 3091856. DOI: 10.1371/journal.pone.0019503. View

20.

ASHMAN C, Davidson R . Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance. Mol Cell Biol. 1981; 1(3):254-60. PMC: 369669. DOI: 10.1128/mcb.1.3.254-260.1981. View